Bonafide Health, established in 2011, is a biotechnology, e-commerce, and healthcare startup based in the United States. The company's mission, as highlighted by the slogan "Stronger by Nature," is to provide women with naturally powerful remedies for various natural symptoms they experience throughout their lives, from PMS to menopause and beyond.
Backed by experts with over 50 years of experience in medical drug discovery, clinical research, and patient advocacy, Bonafide is committed to creating solutions that leverage natural ingredients to treat women's health issues. Their portfolio consists of non-prescription, hormone-free products that are rigorously researched, developed, and scientifically validated to ensure effectiveness and safety.
One of the company's key differentiators is their focus on safety, with all Bonafide products being crafted with powerful yet safe ingredients, free from hormones and adverse side effects. The company also emphasizes the importance of education, providing resources about natural products to healthcare providers across the country. Notably, Bonafide products come highly recommended by over 8,600 healthcare providers due to their strong data and safety measures.
In their latest funding round, Bonafide Health secured a significant $25.00M debt financing investment on 01 January 2021. Despite not disclosing the specific investors involved, this investment is indicative of the potential and promise perceived in the company's innovative approach to women's healthcare.
With a clear focus on addressing the unique health needs of women through natural remedies supported by sound research and safety measures, Bonafide Health appears poised for continued growth and impact in the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $25.00M | - | 01 Jan 2021 |
No recent news or press coverage available for Bonafide Health.